Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

Ventus has entered a multi-year partnership with Roche’s Genentech for the discovery and optimisation of new small-molecule ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

In the rapidly evolving field of drug discovery, single-cell analysis has become an invaluable tool for understanding cellular heterogeneity and molecular pathways. However, traditional single-cell ...

ANN ARBOR, Mich. & NEW YORK--(BUSINESS WIRE)--A new partnership between the University of Michigan (U-M) and health care investment firm Deerfield Management Co. will create a company to commercialize ...

Senior Vice President of Clinical Development WALTHAM, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher Jeffrey Agar and a team of scientists came up with a technique that improves ...

The big, unopened boxes of lab equipment that crowd one room at the recently expanded Skaggs Pharmaceutical Sciences Center are a sign of things to come for drug research at the University of Arizona.